Comment on “bevacizumab or laser for aggressive posterior retinopathy of prematurity”
Sign Up to like & getrecommendations! Published in 2019 at "Taiwan Journal of Ophthalmology"
DOI: 10.4103/tjo.tjo_139_18
Abstract: However, a few points need to be answered. The authors did not categorize the outcomes with respect to zones of involvement. Although classically APROP is seen in Zone I, it can be seen in posterior… read more here.
Keywords: laser aggressive; laser; aggressive posterior; bevacizumab laser ... See more keywords